AC
Amia Capital Portfolio holdings
AUM
$32.1M
This Quarter Return
+22.26%
1 Year Return
-3.89%
3 Year Return
+25.64%
5 Year Return
–
10 Year Return
–
AUM
$121M
AUM Growth
+$121M
(+8%)
Cap. Flow
-$5.7M
Cap. Flow
% of AUM
-4.7%
Top 10 Holdings %
Top 10 Hldgs %
87.42%
Holding
43
New
2
Increased
3
Reduced
32
Closed
4
Top Buys
Top Sells
| 1 |
Liberty Latin America Class A
LILA
|
$4.89M |
| 2 |
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
|
$4.32M |
| 3 |
Grifois
GRFS
|
$4.13M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$1.44M |
| 5 |
Moderna
MRNA
|
$1.28M |
Sector Composition
| 1 | Healthcare | 42.82% |
| 2 | Energy | 7.16% |
| 3 | Materials | 2.98% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Grifois
GRFS
$6.59B
| $28.8M | 23.64% |
1,577,297
-226,559
| -13% | -$4.13M |
|
|
LSXMK
2
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $19.4M | 15.9% |
561,687
+163,652
| +41% | +$5.64M |
|
|
LSXMA
3
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $18.9M | 15.51% |
546,619
-125,122
| -19% | -$4.32M |
|
|
BBL
4
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $17.6M | 14.46% |
427,696
+198,777
| +87% | +$8.18M |
|
5
Petrobras
PBR
$80B
| $8.68M | 7.14% |
1,050,000
+1,040,000
| +10,400% | +$8.6M |
|
6
Vale
VALE
$43.4B
| $3.61M | 2.97% |
350,000
-100,000
| -22% | -$1.03M |
|
|
7
Ionis Pharmaceuticals
IONS
$9.16B
| $2.67M | 2.19% |
45,199
-24,479
| -35% | -$1.44M |
|
8
Neurocrine Biosciences
NBIX
$14.1B
| $2.23M | 1.83% |
18,299
-9,840
| -35% | -$1.2M |
|
9
Vertex Pharmaceuticals
VRTX
$103B
| $2.13M | 1.75% |
7,351
-3,458
| -32% | -$1M |
|
10
Incyte
INCY
$16.8B
| $2.06M | 1.69% |
19,792
-9,843
| -33% | -$1.02M |
|
|
11
Moderna
MRNA
$9.41B
| $1.42M | 1.16% |
22,048
-19,945
| -47% | -$1.28M |
|
12
Alnylam Pharmaceuticals
ALNY
$58.6B
| $1.39M | 1.14% |
9,404
-4,542
| -33% | -$673K |
|
13
Halozyme
HALO
$8.58B
| $1.23M | 1.01% |
45,934
-23,475
| -34% | -$629K |
|
14
argenx
ARGX
$43.2B
| $1.2M | 0.98% |
5,316
-2,919
| -35% | -$657K |
|
15
Agios Pharmaceuticals
AGIO
$2.28B
| $1.18M | 0.97% |
22,096
-11,862
| -35% | -$635K |
|
16
Esperion Therapeutics
ESPR
$468M
| $1.07M | 0.88% |
20,903
-11,589
| -36% | -$595K |
|
|
ALXN
17
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $836K | 0.69% |
7,447
-4,005
| -35% | -$450K |
|
18
MacroGenics
MGNX
$110M
| $709K | 0.58% |
25,403
-13,986
| -36% | -$390K |
|
|
MYOK
19
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $687K | 0.56% |
7,109
-3,910
| -35% | -$378K |
|
20
iShares Biotechnology ETF
IBB
$5.69B
| $686K | 0.56% |
5,015
-6,192
| -55% | -$847K |
|
|
ITCI
21
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $657K | 0.54% |
25,602
-4,542
| -15% | -$117K |
|
|
MYOV
22
DELISTED
Myovant Sciences Ltd.
MYOV
| $558K | 0.46% |
27,070
-14,900
| -36% | -$307K |
|
|
RDUS
23
DELISTED
Radius Health, Inc.
RDUS
| $525K | 0.43% |
38,551
-21,432
| -36% | -$292K |
|
24
Exelixis
EXEL
$10B
| $378K | 0.31% |
15,943
-8,769
| -35% | -$208K |
|
25
Nektar Therapeutics
NKTR
$553M
| $341K | 0.28% |
14,733
-8,109
| -36% | -$188K |
|